Sir, Having read the article by Moghaddam et al1, I would like to bring to light a new foray of monoclonal antibodies in to antibacterial actions especially against Staphylococcus aureus.The active and passive immunity approaches targeting S. aureus, particularly methicillin-resistant S. aureus (MRSA), have been quite promising.
Loading....